BCMA laying groundwork for next master agreement talksCurrent deal dictates negotiation work must begin in April, discussions in May What if ... we started life with a genetic risk report card?The power of genetic testing is enormous, but information is flowing too fast for even doctors to understand it The Beauty of 2011 Canadians are hooked on beauty, and nothing will stop them from stocking up on look-better products. Unearthing the latest in new drugs A look at novel agents in the late stages of development in Canada. New access-to-care system goes live A museum visit—the pharmacy way Our writer explores the wonders of early alchemy on a recent trip to Switzerland. GPs snug in a growing ‘quilt’ of programs British Columbia tries different types of programs in different situations to assist primary-care doctors Aclasta: reports of renal dysfunction Reports made of renal dysfunction associated with Aclasta solution for intravenous infusion. Drug News: Finacea, FluMist, Intanza Finacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. New Canadian flu guidelines target traditional and new high-risk groups First Previous 8 9 10 11 12 Next Last
